1. What Is the Cell Sorting Chip Market?
The Cell Sorting Chip Market covers microfluidic and acoustic chip platforms separating cell populations from biological samples for research, clinical diagnostics, and cell therapy manufacturing. Cell sorting chips encompass deterministic lateral displacement chips, dielectrophoresis sorting devices, acoustic cell focusing chips, and microfluidic affinity capture platforms. Market dynamics reflect cell therapy manufacturing requiring GMP-grade sorting, liquid biopsy driving circulating tumour cell isolation, and single-cell biology requiring highly pure populations for downstream sequencing.
2. Cell Sorting Chip Market Size & Forecast
3. Emerging Technologies
- Microfluidic size-based cell sorting chips enabling circulating fetal cell isolation from maternal blood for non-invasive prenatal diagnosis are advancing. Growing clinical adoption is driven by chromosomal aneuploidy diagnosis from intact fetal cells.
- Integrated single-cell sorting and sequencing chips enabling direct cell capture and library preparation on-chip are advancing as workflow tools. Growing adoption at single-cell genomics labs is driven by cell loss reduction requirements.
- Continuous cell sorting chips processing fermentation broth for bioprocess monitoring are advancing as industrial biotechnology tools. Growing adoption at biomanufacturing operations is driven by continuous process analytical technology requirements.
- High-throughput droplet sorting chips using fluorescence-activated sorting at millions of droplets per hour are advancing as directed evolution tools. Growing adoption at protein engineering groups is driven by ultra-high throughput screening requirements.
Such innovations are driving change across adjacent industries too. Discover more in our Microfluidic Chip Market.
4. Key Market Opportunity
The leading opportunity in the Cell Sorting Chip Market is the cell therapy manufacturing sub-market, where CAR-T, CAR-NK, and TIL cell therapy production creates large GMP-grade cell sorting chip consumable demand. Liquid biopsy CTC isolation creates a growing clinical revenue opportunity as cancer monitoring applications validate chip-based rare cell capture. Single-cell biology creates a high-volume research consumable channel as single-cell RNA sequencing requires high-purity sorted cell populations. Asia Pacific cell therapy manufacturing expansion creates geographic opportunity as Chinese and Korean companies scale manufacturing operations.
5. Top Companies in the Cell Sorting Chip Market
The following organisations hold leading positions in the Cell Sorting Chip Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Miltenyi Biotec (CliniMACS)
- Angle (RareCyte)
- Menarini Silicon Biosystems
- Vortex Biosciences
- Clearbridge Biomedics
- AcouSort
- Becton Dickinson (Microfluidics)
- Cytoskeleton
- Fluidigm
- ThinXXS
6. Market Segmentation
The Cell Sorting Chip Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Technology | Microfluidic DLDAcoustic SortingDEPAffinity CaptureInertial Sorting |
| By Application | CTC IsolationImmune Cell SortingStem CellCell Therapy ManufacturingSingle-Cell |
| By End User | Research LabClinical LabCell Therapy CMOPharmaceutical |
| By Geography | North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Cell Sorting Chip Market trajectory over the forecast period:
Angle Abnova RareCyte Circulating Tumour Cell Chips Achieve Clinical Liquid Biopsy Validation Studies.RareCyte CTC Finder chip achieving 90 percent sensitivity for epithelial CTC capture from peripheral blood achieved CE marking for clinical liquid biopsy in European oncology centres in 2024. CTC-based drug response monitoring in breast and prostate cancer creates clinical biomarker revenue for chip developers.
Miltenyi CliniMACS Cell Sorting Chips Enter GMP Cell Therapy Manufacturing for CAR-T Production.Miltenyi CliniMACS Prodigy integrated closed-system cell sorting chip for CAR-T cell manufacturing achieved FDA clearance for clinical manufacturing in 2024. CAR-T cell manufacturing at 3,000 annual patient doses requiring GMP-grade CD4 and CD8 sorting chips creates recurring cell therapy consumable revenue.
Acoustic Cell Sorting Chips Enable Label-Free Cell Separation Without Biological or Chemical Modification.Acoustofluidic chip sorting using bulk acoustic wave at 1,000 cells per second without surface modification achieved stem cell isolation validation in 2024. Label-free acoustic sorting preserving cell viability and surface marker integrity creates a quality advantage over immunomagnetic sorting for cell therapy.
For related market intelligence, see the Lab On Chip Market.
8. Segmental Analysis
By technology, the Microfluidic Affinity Capture and DLD segment dominated the Cell Sorting Chip Market in 2025. Representing the largest revenue category as CTC capture and immune cell isolation achieve clinical and research scale deployment. The Acoustic Cell Sorting segment is the fastest-growing category, advancing as label-free viability-preserving sorting achieves cell therapy manufacturing validation.
By application, the Cell Therapy Manufacturing segment dominated the Cell Sorting Chip Market in 2025. Representing the largest application revenue share. The CTC Liquid Biopsy segment is the fastest-growing application category, advancing as cloud-native deployment lowers adoption cost and expands mid-market buyer access. The CTC Liquid Biopsy growth rate is outpacing the overall Cell Sorting Chip Market average, gradually shifting application revenue composition through 2034.
By end user, the Research Lab segment dominated the Cell Sorting Chip Market in 2025, as academic single-cell biology, immunology, and stem cell research programmes generate the broadest microfluidic cell sorting platform adoption. Cell Therapy CMO is the fastest-growing end-user category, driven by commercial-scale CAR-T and NK cell therapy manufacturing requiring GMP-compliant microfluidic cell isolation and enrichment systems.
9. Regional Analysis
Regional demand patterns across the Cell Sorting Chip Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Cell Sorting Chip Market in 2025, holding 45.8% of the global market. Academic research institutions, cell therapy manufacturers, and single-cell genomics organisations are deploying cell sorting chip platforms to isolate rare cell populations, purify therapeutic cell products, and enable single-cell multiomics workflows. FDA clinical cell therapy manufacturing requirements and growing NIH investment in single-cell biology research are encouraging organisations to adopt microfluidic cell sorting technologies as alternatives to conventional fluorescence-activated cell sorting. High life sciences R&D investment, expanding cell therapy clinical trial activity, and growing demand for gentle, label-free cell isolation are generating strong regional adoption.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 26.75% during the forecast period. Government biotechnology investment programmes and expanding cell therapy clinical trial activity across China, Japan, South Korea, and Australia are creating institutional demand for cell sorting chip platforms in therapeutic cell manufacturing. Growing adoptions of CAR-T cell therapy and stem cell research are encouraging healthcare organisations to invest in microfluidic cell sorting technologies that improve therapeutic cell product purity and yield. Rising pharmaceutical company investment in cell-based drug development and expanding single-cell genomics research are accelerating cell sorting chip adoption.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Cell Sorting Chip Market was valued at USD 1.40 Bn in 2025 and is projected to reach USD 8.65 Bn by 2034, growing at a CAGR of 22.4% over the 2026–2034 forecast period.
The Cell Sorting Chip Market is projected to grow at a CAGR of 22.4% from 2026 to 2034.
North America accounted for the largest share of the Cell Sorting Chip Market in 2025, holding 45.8% of the global market.
The leading companies in the Cell Sorting Chip Market include Miltenyi Biotec (CliniMACS), Angle (RareCyte), Menarini Silicon Biosystems, Vortex Biosciences, Clearbridge Biomedics, AcouSort, Becton Dickinson (Microfluidics), Cytoskeleton, Fluidigm, ThinXXS.
Angle abnova rarecyte circulating tumour cell chips achieve clinical liquid biopsy validation studies.
By technology, the Microfluidic Affinity Capture and DLD segment dominated the Cell Sorting Chip Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.